This is an old revision of the document!

Beardsworth Consulting Group

Beardsworth Consulting Group was an American contract research organization (CRO) based in Flemington, New Jersey.

History

In June 2010, Beardsworth hired Alison Martin as the company's Scientific Advisor of Oncology and Robert Malone as Scientific Advisor of Vaccines.¹⁾

On April 26, 2013, Beardsworth was acquired by TFS HealthScience.²⁾

Beardsworth's key personnel included:³⁾

Name	Position	Notes
Michael O'Brien	President and CEO	Allerion, Bionx Implants, Biosyn, Biocyte, Deloitte
Alison Martin	Scientific Advisor of Oncology	OncologyOne, National Cancer Institute (NCI), Food and Drug Administration (FDA), Cancer Therapy Evaluation Program (CTEP), American Society of Clinical Oncology (ASCO), Melanoma Research Foundation (MRF)
Robert Malone	Medical Director for Vaccines	Vical, MentaGen, Intradigm, Solvay Biologicals, DynPort Vaccine Company, Aeras Global TB Vaccine Foundation, PATH, Iomai, VaxGen, Journal of Immune Based Therapies and Vaccines
Art Gertel	Vice President of Strategic Regulatory Consulting, Medical Writing, and QA	OncologyOne, Schering-Plough, Roche, iKnowMed, American Medical Writers Association (AMWA), Drug Information Association (DIA), European Medical Writers Association (EMWA), Clinical Data Interchange Standards Consortium (CDISC)
Dan Diaz	Vice President of Business Development	Merrell Dow Pharmaceuticals, Marion Laboratories, OncologyOne
Evette Riegel	Senior Director, Clinical Operations and Project Management	IQVIA, Discovery Laboratories, ViroPharma and Wyeth
Linda Diehl Martz	Executive Director of Clinical Data Management and Project Director	Johnson & Johnson, Overlook Hospital

¹⁾

²⁾

³⁾

Key Personnel. Beardsworth. Retrieved January 19, 2012, from https://archive.ph/HTZ5b